This increase in IL-17 activates the NF-κB pathway in the colonic epithelium, which leads to the secretion of chemokines that recruit myeloid-derived suppressor cells that ultimately favor tumor evasion of the immune response [184,185,186]. This evidence concerns the gene NFKB1 and neoplasm.